PREVENTION OF MUSCLE CRAMPS IN HÆMODIALYSIS PATIENTS BY QUININE SULPHATE

D. M. Kaji; W. G. Nottage; A. Ackad; R. M. Stein

doi:10.1016/S0140-6736(76)92286-8

PREVENTION OF MUSCLE CRAMPS IN HÆMODIALYSIS PATIENTS BY QUININE SULPHATE

D. M. Kaji
, W. G. Nottage
, A. Ackad
, R. M. Stein

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Abstract

Nine patients on maintenance hæmodialysis with frequent muscle cramps were given 320 mg quinine sulphate or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks. The frequency of cramps was significantly reduced during dialysis in patients receiving quinine sulphate. None of the hæmatological, auditory, or visual disturbances ascribed to quinine sulphate were noted.

Original language	English
Pages (from-to)	66-67
Number of pages	2
Journal	The Lancet
Volume	308
Issue number	7976
DOIs	https://doi.org/10.1016/S0140-6736(76)92286-8
State	Published - 10 Jul 1976

Access to Document

10.1016/S0140-6736(76)92286-8

Cite this

@article{427ffbb7a52440769429f601e59296e2,

title = "PREVENTION OF MUSCLE CRAMPS IN H{\AE}MODIALYSIS PATIENTS BY QUININE SULPHATE",

abstract = "Nine patients on maintenance h{\ae}modialysis with frequent muscle cramps were given 320 mg quinine sulphate or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks. The frequency of cramps was significantly reduced during dialysis in patients receiving quinine sulphate. None of the h{\ae}matological, auditory, or visual disturbances ascribed to quinine sulphate were noted.",

author = "Kaji, \{D. M.\} and Nottage, \{W. G.\} and A. Ackad and Stein, \{R. M.\}",

note = "Funding Information: tolerance stimulate in study of other with methods cold urticaria for treatment and should of hista-also mine-induced skin reactions, including use of chromone- like drugs{\textquoteright}t which inhibit histamine release, and com- bined therapy with H1 and H2 histamine antagonists.12 This work was supported by the Medical Research Council, the Wellcome Trust, and the Nuffield Trust. Miss Maureen Davison pro- vided excellent technical assistance. We thank our consultant col- leagues for referring patients for study. Requests for reprints should be addressed to M.",

year = "1976",

month = jul,

day = "10",

doi = "10.1016/S0140-6736(76)92286-8",

language = "English",

volume = "308",

pages = "66--67",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "7976",

}

TY - JOUR

T1 - PREVENTION OF MUSCLE CRAMPS IN HÆMODIALYSIS PATIENTS BY QUININE SULPHATE

AU - Kaji, D. M.

AU - Nottage, W. G.

AU - Ackad, A.

AU - Stein, R. M.

N1 - Funding Information: tolerance stimulate in study of other with methods cold urticaria for treatment and should of hista-also mine-induced skin reactions, including use of chromone- like drugs’t which inhibit histamine release, and com- bined therapy with H1 and H2 histamine antagonists.12 This work was supported by the Medical Research Council, the Wellcome Trust, and the Nuffield Trust. Miss Maureen Davison pro- vided excellent technical assistance. We thank our consultant col- leagues for referring patients for study. Requests for reprints should be addressed to M.

PY - 1976/7/10

Y1 - 1976/7/10

N2 - Nine patients on maintenance hæmodialysis with frequent muscle cramps were given 320 mg quinine sulphate or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks. The frequency of cramps was significantly reduced during dialysis in patients receiving quinine sulphate. None of the hæmatological, auditory, or visual disturbances ascribed to quinine sulphate were noted.

AB - Nine patients on maintenance hæmodialysis with frequent muscle cramps were given 320 mg quinine sulphate or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks. The frequency of cramps was significantly reduced during dialysis in patients receiving quinine sulphate. None of the hæmatological, auditory, or visual disturbances ascribed to quinine sulphate were noted.

UR - https://www.scopus.com/pages/publications/0017140416

U2 - 10.1016/S0140-6736(76)92286-8

DO - 10.1016/S0140-6736(76)92286-8

M3 - Article

C2 - 59150

AN - SCOPUS:0017140416

SN - 0140-6736

VL - 308

SP - 66

EP - 67

JO - The Lancet

JF - The Lancet

IS - 7976

ER -

PREVENTION OF MUSCLE CRAMPS IN HÆMODIALYSIS PATIENTS BY QUININE SULPHATE

Abstract

Access to Document

Fingerprint

Cite this